GlassScriptPhysician profile
Nicholas D Frank
NPI 1942475454
$1,707.02
in general payments reported to CMS, 2019-2025
8 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $12.66 · 2021: $110 · 2022: $35.80 · 2023: $53.74 · 2024: $68.74 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,461.24 | 2019-2025 | General - Vascular Intervention, Jetstream Sc |
| Medtronic, INC. | $139.46 | 2022-2025 | Hawkone, Venaseal, Abre |
| Terumo Medical Corporation | $28.98 | 2025 | Glidesheath Slender |
| Musculoskeletal Transplant Foundation INC. | $17.00 | 2019 | |
| Urgo Medical North America, LLC | $16.78 | 2023 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Argon Medical Devices, INC. | $16.26 | 2025 | Clot Management |
| W. L. Gore & Associates, INC. | $15.79 | 2023 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Angiodynamics, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.